Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Am Pharm Assoc (2003). 2009 Jan-Feb;49(1):12-7. doi: 10.1331/JAPhA.2009.08030.

Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective.

Author information

  • 1College of Pharmacy, University of Iowa, Iowa City, IA 52242, USA.

Abstract

OBJECTIVE:

To determine the net financial gain or loss for herpes zoster vaccination services provided to patients from the perspective of an independent community pharmacy.

DESIGN:

Retrospective review of pharmacy records over the program's initial 11-month period.

SETTING:

Independent community pharmacy in Iowa City, IA.

PARTICIPANTS:

Patients received immunization with the herpes zoster vaccine from a certified pharmacist.

INTERVENTION:

Herpes zoster vaccination services were provided to the patient and documented by the pharmacist.

MAIN OUTCOME MEASURE:

Net financial gains or losses were calculated for the herpes zoster vaccination program. Sensitivity analyses were based on costs that might be incurred during program start-up.

RESULTS:

478 patients received zoster vaccination services over the initial 11-month period. A net financial gain for the herpes zoster vaccination program was achieved, with a net profit of $15.02, or 8.15%, per vaccination.

CONCLUSION:

Revenues for this vaccination program exceeded its costs from the independent community pharmacy perspective.

PMID:
19196591
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Silverchair Information Systems
    Loading ...
    Write to the Help Desk